Germany’s Merck to boost lab-tools business with $11 billion Bio-Techne deal

The proposed acquisition will be the company’s biggest deal in more than a decade and represents an early move by new CEO Kai ...
News-Medical.Net

Merck Kgaa, Darmstadt, Germany, agrees to acquire Bio-Techne, strengthening leadership position in fast-growing life sciences markets

Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Bio-Techne Corporation, a Minneapolis-based ...
BioPharma Dive

‘The window’s open’: At BIO, investors take stock of a growing class of biotech IPOs

In interviews as well as a panel at BIO’s annual meeting, investors and life sciences bankers predicted an acceleration in ...
STAT

At BIO 2026, industry wrestled with Washington politics, and making AI work better

At BIO 2026, executives reveal concerns over Chinese biotech, the profitability of AI, and the durability of Trump's drug ...
Contract Pharma

Enzene Launches Nex Partnership Initiative at BIO

Enzene debuted its comprehensive, end-to-end Nex partnership program at the 2026 BIO International Convention in San Diego.

U.K. Biotechnology Company RQ Bio Completes $115 Million Series A Funding

U.K. biotechnology company RQ Bio has completed a $115 million Series A funding round to support the development of its lead antibody program and help advance the its broader pipeline of therapies.
China Daily

Hong Kong biotech delegation makes strong US showing at BIO 2026

Hong Kong made a significant mark at the BIO International Convention 2026 in San Diego, California this week, with its ...

BIO CEO says more consistency needed in FDA review process

By Deena Beasley SAN DIEGO, June 23 (Reuters) - U.S. biotechnology industry trade group BIO worked with the Food and Drug Administration on plans announced on Monday to speed clinical trials and ...